Benzinga | Aug 5, 2020 06:14AM EDT

HC Wainwright & Co. Initiates Coverage On Phio Pharmaceuticals with Buy Rating, Announces Price Target of $4

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Phio Pharmaceuticals (NASDAQ:PHIO) with a Buy rating and announces Price Target of $4.